It also inhibits tumor metastasis in hepatocellular carcinoma by targeting the δ opioid receptor (DOR)/epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase (ERK) pathway40,41. Here, EGFR is linked to neoplasm.